Search
Meet NewBiologix, an innovative Swiss biotech company dedicated to revolutionizing the field of gene therapy
At #ASGCT2025, we met up with Founder and CEO Igor Fisch, who described the pillars that make NewBiologix a partner of choice in the rAAV...
3 days ago
Teresa Nunes, M.D., MSC, MBA, Chief Medical Officer at Allucent, explores her role and the therapeutic areas she supports, with a focus on neuroscience
She shares how Allucent’s deep experience in neuro-related clinical trials helps small and mid-sized biotech companies overcome complex...
Apr 30
Allucent: Alex MacDonald, VP, Global Head of Model-Informed Drug Development at Allucent, discusses how his team supports biotech companies throughout the drug development journey
From the role of Clinical Pharmacology Modeling and Simulation to designing smarter early-phase studies and anticipating emerging trends,...
Apr 23
Checking in on the progress of Trinity by Breakthrough in Oxford, UK
After its recent topping off ceremony, BiotechTV's Amy Brown checked in on the construction progress of Trinity by Breakthrough...
Apr 8
HSBC Innovation Banking: Q1 2025 Venture Numbers for Healthcare
HSBC's  Jonathan Norris shares an update on Q1 venture numbers for healthcare, and how the venture side of the sector is holding up in...
Apr 4
At the recent Timmerman Report west coast anniversary celebration, HSBC Innovation Banking's Jesse Essaff discussed Seattle's venture environment and how HSBC helps entrepreneurs
A director at HSBC Innovation Banking for biopharma, diagnostics, and tools, he shares the data on the current environment both for...
Mar 25
Introducing The Savills Studio, a great space in the Prudential Tower that is home to the Boston life sciences team, and is available for clients and future clients to use for work or events
Reach out to learn more about how this expert team can help you find and build out your lab space. Featuring: Chris Gorczyca  | Corporate...
Mar 10
Paula Brown Stafford, CEO of the global CRO Allucent, discusses how the company is purpose built to partner with mid-to-small sized biopharma companies on their success
She describes what appealed to her about Allucent when she took the CEO job in July of last year, and highlights the company's regulatory...
Feb 13
One Canal by Breakthrough - Ready for immediate occupancy in Cambridge, MA
Biotech companies looking for office and lab space in the heart of Cambridge, look no further. One Canal by Breakthrough , on First...
Feb 4
Jon Norris shares highlights from the 2024 HSBC Venture Healthcare Full-Year Report
He provides a 2024 year-end recap and 2025 outlook DOWNLOAD THE FULL REPORT #Sponsored
Jan 10
Wrapping up the summer and looking ahead to biotech's post Labor Day news flow with NYSE's Eric Dimise from Kendall Square
He discusses the sector's IPO activity YTD, what we might expect through the end of the year, and what types of companies have the best...
Aug 29, 2024
Kicking off the Health 2035 Summit in New York with co-hosts Katherine Andersen of HSBC Innovation Banking and Hamid Ghanadan of LINUS
Katherine and Hamid describe today's event that is meant for leaders from across healthcare to discuss and think about where the industry...
Aug 27, 2024
Get to know Allucent -- a full-service, global provider of comprehensive drug development solutions for small and mid-sized biopharmas.
They're on a mission to help bring new therapies to light. Here's how they can help you. Learn more: Allucent.com #sponsored
Jul 9, 2024
One Milestone at Harvard Enterprise Research Campus with biotech legend Arie Belldegrun
Arie Belldegrun discusses Breakthrough Properties, One Milestone at Harvard Enterprise Research Campus, and his take on biotech today....
Jun 12, 2024
One Milestone at Harvard Enterprise Research Campus with Breakthrough Properties' CEO Dan Belldegrun
At an event at Harvard's School of Engineering and Applied Sciences today, Dan Belldegrun describes the future of the Harvard Enterprise...
Jun 12, 2024
Allucent at ASCO 2024
From McCormick Place during #ASCO24, we talk with Brian Abbott, MD, Allucent's Global Head of Oncology, about the latest trends in...
Jun 4, 2024
CRO Keys to Success: Clinical Pharmacology Modeling and Simulation
Allucent's Katy Moore, PharmD, RPh, describes the importance of 'Clinical Pharmacology Modeling and Simulation' to designing clinical...
May 23, 2024
Visiting the future site of Trinity by Breakthrough in Oxford, UK
Thomas Renn, Head of Europe for Breakthrough Properties, introduces us to this state-of-the-art facility that will encompass 214,000...
May 13, 2024
HSBC's Global Capabilities for the Biopharmaceutical Industry
Reece Kresser describes the increasingly global nature of the biopharmaceuticals industry.
Mar 20, 2024
Pfizer Ignite and StudioLabs by Breakthrough Properties announce Partnership
Pfizer Ignite and StudioLabs by Breakthrough Properties are partnering to help biotech entrepreneurs get to work and succeed.
Feb 26, 2024
.png){kind=logo}
